Related Experiment Video
Updated: Jan 24, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Ocular and orbital side effects of ALK inhibitors: a review article
Elias Chelala1, Sandra Hoyek1, Nicolas Arej1
1Saint Joseph University, Faculty of Medicine, Beirut, Lebanon.
Abstract:
ALK inhibitors are a new group of tyrosine kinase inhibitors, highly efficient in the treatment of non-small-cell lung carcinoma. However, these targeted therapies can induce various adverse effects, including ocular toxicity. To date, few articles reporting ophthalmological side effects of ALK inhibitors have been published. In this review, we aim to describe the different side effects and to collect information regarding the causes behind the discrepancy between the reported rates of visual disorders. Frequent ocular side effects of ALK inhibitors included flashes, post-flashbulb effect, stripes, photopsia, accommodation disorder, presbyopia, reduced visual acuity and blurred vision. Optic neuropathy, vitreous floaters, diplopia, cataract and macular edema were also reported.
Insights
Anaplastic lymphoma kinase (ALK) inhibitors, used for non-small-cell lung cancer, can cause ocular toxicity. This review details visual side effects like flashes, blurred vision, and optic neuropathy, aiding understanding of these ALK inhibitor adverse events.
Area of Science:
- Oncology
- Ophthalmology
- Pharmacology
Background:
- Anaplastic lymphoma kinase (ALK) inhibitors are effective targeted therapies for non-small-cell lung carcinoma.
- Ocular toxicity is a known adverse effect of these targeted therapies.
- Limited literature exists on the ophthalmological side effects of ALK inhibitors.
Purpose of the Study:
- To review and describe the spectrum of ocular side effects associated with ALK inhibitors.
- To explore potential reasons for variability in reported visual disorders.
- To consolidate information on visual disturbances caused by ALK inhibitors.
Main Methods:
- Literature review of studies reporting ophthalmological side effects of ALK inhibitors.
- Compilation and categorization of reported ocular adverse events.
- Analysis of potential contributing factors to observed visual disorders.
Main Results:
- Frequent ocular side effects include photopsia, blurred vision, reduced visual acuity, and accommodation disorders.
- Other reported effects encompass optic neuropathy, macular edema, diplopia, and cataract.
- Variability in reported rates of visual disorders may stem from differing methodologies and patient populations.
Conclusions:
- ALK inhibitors can induce a range of ocular toxicities in non-small-cell lung cancer patients.
- Awareness of these visual side effects is crucial for timely diagnosis and management.
- Further research is needed to elucidate the mechanisms and standardize reporting of ALK inhibitor-induced ocular toxicity.
Related Concept Videos
Molecular Orbital Theory II
Hybridization of Atomic Orbitals II
The Energies of Atomic Orbitals
Atomic Orbitals
Hybridization of Atomic Orbitals I
Molecular Orbital Theory I

